Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Teerha Piratvisuth, Sombat Treeprasertsuk et al.|Hepatology International|2020Cited by 295
Global burden of metabolic diseases, 1990–2021Huai Zhang, Omar Thaher, Xiaodong Zhou et al.|Metabolism|2024Cited by 294
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiaodong Zhou, Tamer N. Abdelbaki, Qin‐Fen Chen et al.|EClinicalMedicine|2024Cited by 188
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensusXufen Zeng, Xin Liu, Krista A Varady et al.|Metabolism|2024Cited by 111
Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patientsYu Jun Wong, Juan G. Abraldeṣ, Vincent Chen et al.|Hepatology|2024Cited by 27